(Q42285101)

19 October 2017

Polymorphism of debrisoquine hydroxylation among Finns and Lapps (English)

1 reference

19 October 2017

Arvela P

1

1 reference

19 October 2017

Kirjarinta M

2

1 reference

19 October 2017

Kirjarinta M

3

1 reference

19 October 2017

Kärki N

4

1 reference

19 October 2017

Pelkonen O

5

1 reference

19 October 2017

language of work or name

English

0 references

publication date

1 November 1988

1 reference

British Journal of Clinical Pharmacology

19 October 2017

1 reference

19 October 2017

26

1 reference

19 October 2017

5

1 reference

19 October 2017

601-603

1 reference

A family and population study of the genetic polymorphism of debrisoquine oxidation in a white British population.

19 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1386638

The Upjohn Award Lecture 1981/La Conférence Upjohn 1981. The metabolism of xenobiotics in different populations.

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1386638

The genetic control of sparteine and debrisoquine metabolism in man with new methods of analysing bimodal distributions

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1386638

The genetic control of drug oxidation in the liver.

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1386638

Interethnic differences in genetic polymorphism of debrisoquin and mephenytoin hydroxylation between Japanese and Caucasian populations

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1386638

A family study of genetic and environmental factors determining polymorphic hydroxylation of debrisoquin

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1386638

Confidence intervals rather than P values: estimation rather than hypothesis testing

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1386638

Inhibitory effects of neuroleptics on debrisoquine oxidation in man

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1386638

Clinical Pharmacokinetics of Isoniazid

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1386638

Isoniazid inactivation in Finns and Lapps as demonstrated by various methods

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1386638

Demography of the Skolt Lapps in Northern Finland

29 May 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/3207564

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Determination of debrisoquine and its 4-hydroxy metabolite in biological fluids by gas chromatography with flame-ionization and nitrogen-selective detection

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/3207564

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

[Drug hydroxylation disorders (debrisoquin type) in a random sample of the Swiss population]

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/3207564

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1111/J.1365-2125.1988.TB05301.X

1 reference

19 October 2017

1 reference

19 October 2017

1 reference